Regenerative medicine: current applications, challenges and future directions


20 Sept.			14:00 - 15:30



YOUNGINNOVATION		HEALTH & NANOMEDICINE
THE STATE OF RESEARCH COMMUNICATED BY YOUNG RESEARCHERS
TT.III - Technical Multi-Track with Parallel SYMPOSIA
Regenerative medicine: current applications, challenges and future directions
Co-organized with University Magna Graecia of Catanzaro and Sapienza University of Rome Chair: Francesca MEGIORNI, Sapienza University of Rome
Regenerative medicine represents a beacon of hope in modern healthcare, promising solutions for degenerative diseases and tissue damage. This session delves into the multifaceted landscape of regenerative medicine, charting its present achievements, grappling with existing obstacles, and envisioning the bold trajectories that lie ahead. Current applications of regenerative medicine span a diverse spectrum, from stem cell therapies to tissue-engineered constructs fostering organ regeneration. These breakthroughs underscore the potential to mend the human body at its most fundamental level, encouraging natural healing processes to restore vitality. However, the path to full realization is not without hurdles. The challenges of immune rejection, ethical considerations, and ensuring safe, standardized protocols demand careful exploration. Looking forward, regenerative medicine holds the promise of tailored treatments, personalized to an individual's genetic makeup and medical history. Innovations such as organ printing, gene editing, and bioactive scaffolds are poised to redefine healthcare paradigms, bridging the gap between science fiction and tangible medical solutions.
*The symposium is part of the Special Event SE.I*
TT.III.F.1 SE.I.3.1	Introductive Keynote Simona CECCARELLI Sapienza University of Rome Advances in regenerative medicine: from tissue engineering and cell-based therapies to microfluidics technology
TT.III.F.2 SE.I.3.2	Daniela ROSSIN - CV University of Turin Revolutionizing Cardiac Therapy: 3FEEP - A Nanofunctionalized Scaffold for Post-Myocardial Infarction Tissue Protection and Regeneration
TT.III.F.3 SE.I.3.3	Francesco PASQUALINI University of Pavia Instrumented human stem cells for drug discovery, disease modeling, and regenerative medicine
TT.III.F.4 SE.I.3.4	Paola PONTECORVI - CV Sapienza University of Rome Tissue engineering in Mayer-Rokitansky-Küster-Hauser syndrome: state of the art and future perspectives
TT.III.F.5 SE.I.3.5	Domenica CONVERTINO - CV Center for Nanotechnology Innovation, IIT, Pisa Interaction of graphene and WS2 with neutrophils and mesenchymal stem cells: implications for peripheral nerve regeneration